AllSci
Developer of an AI-powered research intelligence platform that transforms scientific literature into structured hypotheses, research questions, and linked evidence. The platform provides large-scale indexing and semantic linking of publications, interactive visualizations, institutional analytics, and an open publishing/continuous peer-review workflow aimed at accelerating discovery in academia and life-science R&D.
Industries
Nr. of Employees
small (1-50)
Products
Atomization technology and hypothesis database
A platform capability that deconstructs scientific articles into core components (hypotheses, research questions, results) and indexes them into a searchable database for discovery and verification.
AERIS
AllSci Enhanced Research Intelligence System, an AI-powered research intelligence platform for pharma & biotech that leverages advanced language models to break down scientific publications into hypotheses, research questions, and results, delivering unmatched clarity and accessibility.
AllSci AI-Powered Research Platform
An AI-powered research platform designed for biopharma to uncover hypothesis-driven insights, explore over 12 million extracted hypotheses and research questions, analyze peer programs and publication networks, benchmark outputs, and track the evolution of concepts and pathways.
Pro Plan
Plan for working professionals with R&D intelligence, AI-driven workflows, and highest usage limits.
Plus Plan
Plan for dabbling researchers with expanded content access, deep research chat, analytics, and higher AI usage limits.
Enterprise Plan
Custom plan for teams and organizations with SSO, volume licensing, dedicated onboarding, and organization benchmarking.
Atomization technology and hypothesis database
A platform capability that deconstructs scientific articles into core components (hypotheses, research questions, results) and indexes them into a searchable database for discovery and verification.
AERIS
AllSci Enhanced Research Intelligence System, an AI-powered research intelligence platform for pharma & biotech that leverages advanced language models to break down scientific publications into hypotheses, research questions, and results, delivering unmatched clarity and accessibility.
AllSci AI-Powered Research Platform
An AI-powered research platform designed for biopharma to uncover hypothesis-driven insights, explore over 12 million extracted hypotheses and research questions, analyze peer programs and publication networks, benchmark outputs, and track the evolution of concepts and pathways.
Pro Plan
Plan for working professionals with R&D intelligence, AI-driven workflows, and highest usage limits.
Plus Plan
Plan for dabbling researchers with expanded content access, deep research chat, analytics, and higher AI usage limits.
Enterprise Plan
Custom plan for teams and organizations with SSO, volume licensing, dedicated onboarding, and organization benchmarking.
Services
Partnership offering early access to the platform's hypothesis datasets, visualization tools, and AI capabilities to inform R&D portfolio strategy and collaborative research.
Partnership offering early access to the platform's hypothesis datasets, visualization tools, and AI capabilities to inform R&D portfolio strategy and collaborative research.
Expertise Areas
- AI-driven literature analysis
- Hypothesis generation and curation
- Knowledge graphs and semantic linking
- Research visualization and lineage mapping
Key Technologies
- Natural language processing (NLP)
- Knowledge graphs
- Semantic search
- AI-driven evidence extraction
News & Updates
Announcement of the platform beta launch and the atomization technology that decomposes articles into hypotheses, research questions, and results.
Announcement of a partner program offering early access to hypothesis datasets, visualization tools, and the AI research engine for pharma and biotech organizations.
Press release reporting award of a grant from a regional technology innovation fund to scale the AI engine, visualization tools, and develop dedicated dashboards for biotech and pharma.
Received a grant to support scaling the AI engine, visualization tools, and development of research dashboards for biotech and pharma R&D.
Announcement of the platform beta launch and the atomization technology that decomposes articles into hypotheses, research questions, and results.
Announcement of a partner program offering early access to hypothesis datasets, visualization tools, and the AI research engine for pharma and biotech organizations.
Press release reporting award of a grant from a regional technology innovation fund to scale the AI engine, visualization tools, and develop dedicated dashboards for biotech and pharma.
Received a grant to support scaling the AI engine, visualization tools, and development of research dashboards for biotech and pharma R&D.